MeroGel Injectable nasal packing may help prevent adhesions and middle turbinate lateralization, a common cause of FESS failure.1-3
MeroGel® Injectable nasal packing is a bioresorbable, space-occupying gel stent used after functional endoscopic sinus surgery (FESS) or nasal trauma. It's composed of cross-linked polymers of hyaluronic acid and administered with a flexible catheter for easier access to nasal cavities.
During the important postoperative period, MeroGel Injectable nasal packing is intended to:
Our bioresorbable nasal packing products use hyaluronic acid, a linear polysaccharide and naturally occurring constituent of the extracellular matrix.
Hyaluronic acid helps keep the surgical site moist, reduce adhesions, and decrease healing time.4 Esterified hyaluronic acid, or HYAFF®, is a patented formula that is used in our MeroGel and MeroPack® nasal packing products.
We offer several bioresorbable nasal packing products to suit the needs of your patients, including MeroGel packing and MeroPack. You can also view traditional nasal packing in our ENT Product Catalog.
HYAFF® is a registered trademark of Fidia Advanced Biopolymers.
Musy PY, Kountakis SE. Anatomic findings in patients undergoing revision endoscopic sinus surgery. Am J Otolaryngol. 2004; 25(6):418-422.
Ramadan HH. Surgical causes of failure in endoscopic sinus surgery. Laryngoscope. 1999; 109:27-29.
Kuhn FA, Citardi MJ. Advances in postoperative care following endoscopic sinus surgery. Otolaryngol Clin North Am. 1997; 30(3):479-490.
Berlucchi M, Castelnuovo P, Vincenzi A, Morra B, Pasquini E. Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study. Eur Arch Otorhinolaryngol. 2009; 266(6): 839-845.